PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Hematology, Department of Human Pathology in Adulthood and Childhood \'Gaetano Barresi\', University of Messina, 98125 Messina, Italy.\', \'COVID Centre AOU Policlinic G. Martino, 98125 Messina, Italy.\', \'Department of Medicine and Science of Ageing, G\' d\'Annunzio University, 66100 Chieti, Italy.\', \'Institute for Clinical Immunotherapy and Advanced Biological Treatments, 65100 Pescara, Italy.\', \'Clinical Physiology Institute, National Research Council of Italy (IFC-CNR), 56124 Pisa, Italy.\', \'School and Operative Unit of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • E478210.3390/ijms21134782
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 32640747
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
?:title
  • Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all